Loading...
XJPX4218
Market cap254mUSD
Jan 17, Last price  
1,952.00JPY
1D
-0.76%
1Q
-0.31%
Jan 2017
20.49%
Name

Nichiban Co Ltd

Chart & Performance

D1W1MN
XJPX:4218 chart
P/E
21.75
P/S
0.85
EPS
89.75
Div Yield, %
1.79%
Shrs. gr., 5y
-0.18%
Rev. gr., 5y
-0.24%
Revenues
46.86b
+2.85%
40,567,000,00038,718,000,00037,486,000,00038,521,000,00038,260,000,00038,502,000,00040,225,000,00039,892,000,00042,461,000,00044,145,000,00046,234,000,00047,417,000,00044,063,000,00041,340,000,00043,134,000,00045,560,000,00046,859,000,000
Net income
1.83b
-22.94%
909,000,000757,000,000911,000,000943,000,000692,000,000988,000,000989,000,0001,311,000,0001,827,000,0003,107,000,0003,132,000,0003,193,000,0001,751,000,0001,350,000,0001,809,000,0002,371,000,0001,827,000,000
CFO
3.19b
+9.26%
3,480,000,0003,094,000,0003,894,000,0003,068,000,0002,140,000,0003,075,000,0002,666,000,0002,547,000,0004,406,000,0003,899,000,0003,228,000,0005,584,000,0005,749,000,0005,911,000,0004,064,000,0002,917,000,0003,187,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Nichiban Co., Ltd. manufactures and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, dressing tapes, first-aid bandages, hemostatic bandages, and others. The company also provides OTC products, such as anti-inflammatory patches, foot care products, waterproof films, and bandages. In addition, it offers taping tapes comprising cotton, elastic, kinesiology, strapping tapes, and others; and stationery products consisting of cellulose adhesive tapes, double sided tapes, adhesive transfer tapes, book binding tapes, and others. Further, the company provides industrial tapes for non-heavy duty packaging, carton boxes, agricultural use, vehicles, and machinery, as well as specialized tapes; and cellulose, OPP packing, kraft paper, lithographic, and crepe tapes. Nichiban Co., Ltd. was founded in 1918 and is headquartered in Tokyo, Japan.
IPO date
Oct 02, 1961
Employees
1,268
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
46,859,000
2.85%
45,560,000
5.62%
43,134,000
4.34%
Cost of revenue
44,786,000
45,061,000
41,741,000
Unusual Expense (Income)
NOPBT
2,073,000
499,000
1,393,000
NOPBT Margin
4.42%
1.10%
3.23%
Operating Taxes
445,000
1,059,000
751,000
Tax Rate
21.47%
212.22%
53.91%
NOPAT
1,628,000
(560,000)
642,000
Net income
1,827,000
-22.94%
2,371,000
31.07%
1,809,000
34.00%
Dividends
(721,000)
(622,000)
(621,000)
Dividend yield
1.77%
1.56%
1.76%
Proceeds from repurchase of equity
(448,000)
(130,000)
BB yield
1.10%
0.33%
Debt
Debt current
52,000
81,000
634,000
Long-term debt
2,212,000
2,232,000
2,246,000
Deferred revenue
(796,000)
(696,000)
Other long-term liabilities
7,374,000
7,253,000
7,175,000
Net debt
(13,928,000)
(16,657,000)
(15,192,000)
Cash flow
Cash from operating activities
3,187,000
2,917,000
4,064,000
CAPEX
(3,626,000)
(2,895,000)
(3,126,000)
Cash from investing activities
(3,692,000)
(1,153,000)
(2,898,000)
Cash from financing activities
(1,225,000)
(867,000)
(691,000)
FCF
(1,251,000)
(961,000)
(719,000)
Balance
Cash
13,405,000
15,108,000
14,200,000
Long term investments
2,787,000
3,862,000
3,872,000
Excess cash
13,849,050
16,692,000
15,915,300
Stockholders' equity
38,167,000
76,180,000
72,787,000
Invested Capital
37,361,950
31,918,000
31,568,700
ROIC
4.70%
2.08%
ROCE
4.05%
1.01%
2.89%
EV
Common stock shares outstanding
20,538
20,682
20,721
Price
1,984.00
3.17%
1,923.00
13.12%
1,700.00
-11.18%
Market cap
40,746,874
2.45%
39,771,203
12.90%
35,226,003
-11.18%
EV
26,818,874
62,676,203
58,033,003
EBITDA
4,868,000
3,256,000
3,938,000
EV/EBITDA
5.51
19.25
14.74
Interest
37,000
37,000
37,000
Interest/NOPBT
1.78%
7.41%
2.66%